Related Experiment Video
Updated: Jul 31, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
MiR-125b-5p/STAT3 Axis Regulates Drug Resistance in Osteosarcoma Cells by Acting on ABC Transporters
Yang Yang1, Yueyuan Chen2, Jiajia Liu1
1Department of Trauma Center, Affiliated Hospital of Nantong University, Nantong City, Jiangsu Province 226001, China.
Background:
The poor prognosis of the highly malignant tumor osteosarcoma stems from its drug resistance and therefore exploring its resistance mechanisms will help us identify more effective treatment options. However, the effects of miR-125b-5p on drug resistance in osteosarcoma cells are still unclear.
Methods:
To study the effects of miR-125b-5p on drug resistance in osteosarcoma cells. Osteosarcoma-resistant miR-125b-5p was obtained from the databases GeneCards and g:Profiler. CCK8, western blot, and transwell were applied for the detection of the miR-125b-5p effects on proliferation, migration, invasion, apoptosis, and drug resistance in osteosarcoma. Bioinformatics is aimed at demonstrating the targeting factor miR-125b-5p, performing protein interaction enrichment analysis by Metascape, and finally validating by binding sites.
Results:
Upregulation of miR-125b-5p restrains proliferation, migration, and invasion of osteosarcoma and promotes apoptosis. In addition, miR-125b-5p can restore drug sensitivity in drug-resistant osteosarcoma. miR-125-5p restrains the signal transducer and inhibits the transcription 3 (STAT3) expression activator via targeting its 3'-UTR. STAT3 affects drug-resistant osteosarcoma to regulate the ABC transporter.
Conclusion:
miR-125b-5p/STAT3 axis mediates the drug resistance of osteosarcoma by acting on ABC transporter.
Insights
MicroRNA-125b-5p enhances osteosarcoma drug sensitivity by inhibiting the STAT3 pathway, which regulates ABC transporters. This finding offers new therapeutic strategies for drug-resistant osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma exhibits poor prognosis due to drug resistance.
- Understanding resistance mechanisms is crucial for developing effective treatments.
- The role of miR-125b-5p in osteosarcoma drug resistance remains unclear.
Purpose of the Study:
- To investigate the effects of miR-125b-5p on drug resistance in osteosarcoma cells.
- To elucidate the molecular mechanisms underlying miR-125b-5p's role in osteosarcoma.
- To identify potential therapeutic targets for overcoming drug resistance.
Main Methods:
- Osteosarcoma-resistant miR-125b-5p was identified using bioinformatics databases.
- Cell proliferation, migration, invasion, and apoptosis were assessed using CCK8, western blot, and transwell assays.
- Bioinformatic analysis and binding site validation were employed to identify targeting factors and pathways.
Main Results:
- Upregulation of miR-125b-5p inhibited osteosarcoma cell proliferation, migration, and invasion while promoting apoptosis.
- miR-125b-5p was found to restore drug sensitivity in drug-resistant osteosarcoma cells.
- miR-125b-5p targets the 3'-UTR of signal transducer and activator of transcription 3 (STAT3), inhibiting its expression.
Conclusions:
- The miR-125b-5p/STAT3 axis plays a critical role in mediating osteosarcoma drug resistance.
- STAT3 influences drug resistance in osteosarcoma by regulating ABC transporters.
- Targeting the miR-125b-5p/STAT3 pathway presents a promising strategy for treating drug-resistant osteosarcoma.
Related Concept Videos
ABC Transporters: Exporter
Treatment Resistant Cancers
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Destabilization of Microtubules

